20 LATEST RESOURCES (30 INDEXED)
Safety Monitoring of Oral Iron Supplements in Pregnant Women with Anemia: A Multi-Center Observational Clinical Study · June 2023
Articles
Therapeutic Advances in Drug Safety
Patients’ Attitudes Toward Deprescribing and Their Experiences Communicating with Clinicians and Pharmacists · August 2022
Articles
Therapeutic Advances in Drug Safety
Motivating Deprescribing Conversations for Patients with Alzheimer’s Disease and Related Dementias: a Descriptive Study · August 2022
Articles
Therapeutic Advances in Drug Safety
Risk Communication on Vaccines during the COVID19 Pandemic: Is There Room for Small Size or Private Initiatives? An Israeli Experience · August 2022
Articles
Therapeutic Advances in Drug Safety
Characteristics of Voluntary Reporting of Adverse Drug Events Related to Antipsychotics in Australia: 14-Year Analysis · May 2021
Articles
Therapeutic Advances in Drug Safety
Prescribing Cascades in Persons with Alzheimer’s Disease: Engaging Patients, Caregivers, and Providers in a Qualitative Evaluation of Print Educational Materials · October 2020
Articles
Therapeutic Advances in Drug Safety
QT Interval Prolongation and Torsades De Pointes with Donepezil, Rivastigmine and Galantamine · August 2020
Articles
Therapeutic Advances in Drug Safety
A Mixed Methods Analysis of Lithium-Related Patient Safety Incidents in Primary Care · June 2020
Articles
Therapeutic Advances in Drug Safety
Coprescription of QT Interval-Prolonging Antipsychotics with Potentially Interacting Medications in Thailand · June 2019
Articles
Therapeutic Advances in Drug Safety
Safety and Effectiveness of Cannabinoids for the Treatment of Neuropsychiatric Symptoms in Dementia: A Systematic Review · May 2019
Articles
Therapeutic Advances in Drug Safety
Patient-Focused Interventions to Support Vulnerable People Using Oral Anticoagulants: A Narrative Review · May 2019
Articles
Therapeutic Advances in Drug Safety
The Impact of in Hospital Patient-Education Intervention on Older People’s Attitudes and Intention to Have Their Benzodiazepines Deprescribed: A Feasibility Study · January 2019
Articles
Therapeutic Advances in Drug Safety
Continuation of Atypical Antipsychotic Medications in Critically Ill Patients Discharged from the Hospital: A Single-Center Retrospective Analysis · November 2018
Articles
Therapeutic Advances in Drug Safety
Smoking Cessation in Pregnancy: A Continuing Challenge in the United States · May 2018
Articles
Therapeutic Advances in Drug Safety
Antidepressant Use in Older Inpatients: Current Situation and Application of the Revised STOPP Criteria · May 2018
Articles
Therapeutic Advances in Drug Safety
Evaluating the Risk of QTc Prolongation Associated with Antidepressant Use in Older Adults: A Review of the Evidence · May 2018
Articles
Therapeutic Advances in Drug Safety
Safety of Antipsychotics for the Treatment of Schizophrenia: A Focus on the Adverse Effects of Clozapine · February 2018
Articles
NCBI>Therapeutic Advances in Drug Safety
An Update on the Safety of Current Therapies for Alzheimer’s Disease: Focus on Rivastigmine · January 2018
Articles
NCBI>Therapeutic Advances in Drug Safety
Naloxone Dosage for Opioid Reversal: Current Evidence and Clinical Implications · December 2017
Articles
Therapeutic Advances in Drug Safety
Attention-Deficit Hyperactivity Disorder Medication Use: Factors Involved in Prescribing, Safety Aspects and Outcomes · November 2016
Articles
Therapeutic Advances in Drug Safety